Application of Machine Learning for Early Disease Diagnosis in Healthcare

Machine Learning (ML) is transforming the healthcare field by allowing early detection of diseases with unprecedented accuracy and efficiency by utilizing a variety of data types, including medical imaging, genetic sequences, electronic health records, and physiological data to identify subtle trends and determine the presence of diseases. This paper gives an extensive overview of the application of ML in early detection of critical conditions such as diabetes, cancer, cardiovascular disease, Alzheimer's disease, and sepsis. We explain the entire process, encompassing data collection and preprocessing, model training and validation, and the eventual implementation into a clinical setting. Other models, like convolutional neural networks in radiological image classification and recurrent neural networks in time-series pattern recognition, continue to perform better in terms of sensitivity and specificity than conventional diagnostic techniques. Experiments on the four innovative architectures, including CNN+LSTM Hybrid with an AUC of 0.93, XGBoost+DNN Ensemble at 0.91, Vision Transformer achieving 0.96, and Federated Learning at 0.89, demonstrate their excellent performance as a diagnostic tool. The Vision Transformer is superior in cardiovascular disease (0.976) and diabetes (0.970), whereas Federated Learning dominates in sepsis detection (0.878), recognizing the importance of privacy. Other notable contributions are a comparative paper on model performance and computational efficiency, where training time ranged between 14.2 and 22.8 hours, the application of ethical frameworks addressing bias mitigation and interpretability, but also a real-world validation that showed up to 18 percent performance degradation in community setting environments, informing how to scale deployment. ML holds the potential of an active, personalized, proactive healthcare system lessening diagnostic errors and disparities, yet necessitates interdisciplinary cooperation to mitigate bias, transparency, and regulatory implications yielding equitable, effective clinical integration to global health overall better outcomes.